Aveir Dual-Chamber Leadless i2i IDE Study

Brief description of study

The Aveir DR i2i study will be the first in-human evaluation of the Aveir DR LP system. The purpose of this clinical investigation is to evaluate the clinical safety and effectiveness of the Aveir DR LP system in a patient population indicated for a DDD(R) pacemaker. The results of this clinical investigation will support regulatory pre-market submissions for the Aveir DR LP system for DDD(R) pacing indications and the Aveir atrial LP for AAI(R) pacing indications in various geographies.


Clinical Study Identifier: s21-01237
ClinicalTrials.gov Identifier: NCT05252702
Principal Investigator: Larry A Chinitz.
Other Investigator: Lior Jankelson.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.